Instacart Cuts Internal Valuation Third Time, To $13B

-The Information

-The Information

Total
0
Shares
Related Posts
Read More

Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment

Psychedelics company Clearmind Medicine Inc. (NASDAQ: CMND) aims to bring its proprietary compound, CMND-100, to clinical trials while developing additional proprietary psychedelic compounds for next-generation novel drug candidates, according to CEO Adi Zuloff-Shani.

CMND